Invention Grant
- Patent Title: X-RAY psoralen activated cancer therapy (X-PACT) with associated treatments
-
Application No.: US15992852Application Date: 2018-05-30
-
Publication No.: US11207409B2Publication Date: 2021-12-28
- Inventor: Frederic A. Bourke, Jr. , Mark Dewhirst , Neil Spector , Paul Yoon , Justus Adamson , David Alcorta , Kim Lyerly , Leihua Liu , Takuya Osada , Mark Oldham , Zakaryae Fathi , Wayne F. Beyer , Harold Walder
- Applicant: IMMUNOLIGHT, LLC , DUKE UNIVERSITY
- Applicant Address: US MI Detroit; US NC Durham
- Assignee: IMMUNOLIGHT, LLC,DUKE UNIVERSITY
- Current Assignee: IMMUNOLIGHT, LLC,DUKE UNIVERSITY
- Current Assignee Address: US MI Detroit; US NC Durham
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: A61K41/00
- IPC: A61K41/00 ; A61K31/37 ; A61K45/06 ; A61K9/00 ; A61N5/06 ; A61N5/10 ; A61K31/409 ; A61P35/00

Abstract:
A system (and associated method) for treating a human or animal body. The system has a photoactivatable drug for treating a first diseased site, a first pharmaceutically acceptable carrier including one or more phosphorescent or fluorescent agents which are capable of emitting an activation energy into the body which activates the photoactivatable drug, a first device which infuses the first diseased site with a photoactivatable drug and the first pharmaceutically acceptable carrier, a first energy source which irradiates the diseased site with an initiation energy to thereby initiate emission of the activation energy into the body, and a supplemental treatment device which administers one or both of a therapeutic drug or radiation to the body at a second diseased site or the first diseased site, to provide an immune system stimulation in the body.
Public/Granted literature
- US20180344850A1 X-RAY PSORALEN ACTIVATED CANCER THERAPY (X-PACT) WITH ASSOCIATED TREATMENTS Public/Granted day:2018-12-06
Information query